Series A - Compass Therapeutics, Inc. - Jul 12, 2018 Funding Round Profile - Cointime

Bitcoin $99,370.78 +0.78%
Ethereum $3,292.93 -2.12%
BNB $623.84 -0.02%
Optimism $2.11 +1.62%
Arbitrum $0.77 -1.10%
Solana $255.01 -0.61%
Polygon $0.48 +7.35%
Cosmos $7.31 +15.42%
Avalanche $39.84 +10.51%

Bitcoin $99,370.78 +0.78%
Ethereum $3,292.93 -2.12%
BNB $623.84 -0.02%
Optimism $2.11 +1.62%
Arbitrum $0.77 -1.10%
Solana $255.01 -0.61%
Polygon $0.48 +7.35%
Cosmos $7.31 +15.42%
Avalanche $39.84 +10.51%

Compass Therapeutics, Inc.

company

Funding Round

Series A

Money Raised

$ 49M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Ulysses Diversified Holdings (Ulysses)	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jul 11, 2017	Series A	0	Cowen Investment Management	Detail